Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Comprehensive Protein Expression Analysis of Chronic Lymphocytic Leukemia Uncovers a Correlation of CDK4, P27 and P53 with Hierarchical Risk and Suggests a Dichotomy of Apoptosis and Proliferation.

Dirk Winkler, MD, Christof Schneider, MD, Daniela Nitsch, MD, Kerstin Schulze, Thorsten Zenz, MD, Julia Mohr, Andreas Buehler, MD, Annett Habermann, Manuela Zucknick, Axel Benner, Hartmut Döhner, MD, Stephan Stilgenbauer, MD, Daniel Mertens

Blood (2009) 114 (22): 1255.

https://doi.org/10.1182/blood.V114.22.1255.1255

Published: 2009

Journal Articles

In-Vitro Treatment with the AKT-Inhibitor GSK 690693 Induces Cell Death in Lymphoma Cell Lines and in Primary CLL Cells and Is Followed by Caspase-3 Activation and Cytochrome C Release.

Dirk Winkler, Thorsten Zenz, Daniel Mertens, Annett Habermann, Hartmut Döhner, Stephan Stilgenbauer

Blood (2008) 112 (11): 1589.

https://doi.org/10.1182/blood.V112.11.1589.1589

Published: 2008

Journal Articles

In-Vitro Treatment of Lymphoma Cell Lines with BAY 43-9006 (Sorafenib) Is Followed by Typical Features of Apoptosis and Down-Regulation of MCL-1 Pointing to an Efficacy of Sorafenib in the Teatment of Lymphoma.

Dirk Winkler, MD, Christof Schneider, MD, Annett Habermann, MD, Hartmut Doehner, Stephan Stilgenbauer

Blood (2007) 110 (11): 1392.

https://doi.org/10.1182/blood.V110.11.1392.1392

Published: 2007

Journal Articles

In-Vitro Treatment of Chronic Lymphocytic Leukemia (CLL) Cells with Fludarabine, Etoposide and Alemtuzumab (Campath-1H) Reveals Different Rates and Mechanisms of Cell Death.

Dirk Winkler, MD, Christof Schneider, MD, Daniela Nitsch, Annett Habermann, Hartmut Doehner, MD, Stephan Stilgenbauer, MD

Blood (2005) 106 (11): 2112.

https://doi.org/10.1182/blood.V106.11.2112.2112

Published: 2005

Journal Articles

High ZAP-70 and Differential Expression of B-Cell Receptor Related Genes in Chronic Lymphocytic Leukemia with V3-21 Gene Usage.

Dirk Kienle, Alexander Kröber, Dirk Winkler, Daniel Mertens, Annett Habermann, Peter Lichter, Hartmut Döhner, Stephan Stilgenbauer

Blood (2004) 104 (11): 773.

https://doi.org/10.1182/blood.V104.11.773.773

Published: 2004

Journal Articles

Differential Expression Patterns of Apoptotis and Cell Cycle Proteins after Staurosporine Treatment in EHEB (B-CLL) and JURKAT (T-ALL) Cell Lines.

Dirk Winkler, MD, Daniela Nitsch, Christof Schneider, Annett Habermann, Hartmut Döhner, PHD, Stephan Stilgenbauer, PHD

Blood (2004) 104 (11): 4304.

https://doi.org/10.1182/blood.V104.11.4304.4304

Published: 2004

Journal Articles

V H mutation status and VDJ rearrangement structure in mantle cell lymphoma: correlation with genomic aberrations, clinical characteristics, and outcome

Dirk Kienle, Alexander Kröber, Tiemo Katzenberger, German Ott, Elke Leupolt, Thomas F. E. Barth, Peter Möller, Axel Benner, Annett Habermann, Hans Konrad Müller-Hermelink, Martin Bentz, Peter Lichter, Hartmut Döhner, Stephan Stilgenbauer

Blood (2003) 102 (8): 3003–3009.

https://doi.org/10.1182/blood-2003-05-1383

Published: 2003

NARROW

Comprehensive Protein Expression Analysis of Chronic Lymphocytic Leukemia Uncovers a Correlation of CDK4, P27 and P53 with Hierarchical Risk and Suggests a Dichotomy of Apoptosis and Proliferation.

In-Vitro Treatment with the AKT-Inhibitor GSK 690693 Induces Cell Death in Lymphoma Cell Lines and in Primary CLL Cells and Is Followed by Caspase-3 Activation and Cytochrome C Release.

In-Vitro Treatment of Lymphoma Cell Lines with BAY 43-9006 (Sorafenib) Is Followed by Typical Features of Apoptosis and Down-Regulation of MCL-1 Pointing to an Efficacy of Sorafenib in the Teatment of Lymphoma.

In-Vitro Treatment of Chronic Lymphocytic Leukemia (CLL) Cells with Fludarabine, Etoposide and Alemtuzumab (Campath-1H) Reveals Different Rates and Mechanisms of Cell Death.

High ZAP-70 and Differential Expression of B-Cell Receptor Related Genes in Chronic Lymphocytic Leukemia with V3-21 Gene Usage.

Differential Expression Patterns of Apoptotis and Cell Cycle Proteins after Staurosporine Treatment in EHEB (B-CLL) and JURKAT (T-ALL) Cell Lines.

V H mutation status and VDJ rearrangement structure in mantle cell lymphoma: correlation with genomic aberrations, clinical characteristics, and outcome

Email alerts

ASH Publications

American Society of Hematology

Comprehensive Protein Expression Analysis of Chronic Lymphocytic Leukemia Uncovers a Correlation of CDK4, P27 and P53 with Hierarchical Risk and Suggests a Dichotomy of Apoptosis and Proliferation.

In-Vitro Treatment with the AKT-Inhibitor GSK 690693 Induces Cell Death in Lymphoma Cell Lines and in Primary CLL Cells and Is Followed by Caspase-3 Activation and Cytochrome C Release.

In-Vitro Treatment of Lymphoma Cell Lines with BAY 43-9006 (Sorafenib) Is Followed by Typical Features of Apoptosis and Down-Regulation of MCL-1 Pointing to an Efficacy of Sorafenib in the Teatment of Lymphoma.

In-Vitro Treatment of Chronic Lymphocytic Leukemia (CLL) Cells with Fludarabine, Etoposide and Alemtuzumab (Campath-1H) Reveals Different Rates and Mechanisms of Cell Death.

High ZAP-70 and Differential Expression of B-Cell Receptor Related Genes in Chronic Lymphocytic Leukemia with V3-21 Gene Usage.

Differential Expression Patterns of Apoptotis and Cell Cycle Proteins after Staurosporine Treatment in EHEB (B-CLL) and JURKAT (T-ALL) Cell Lines.

V H mutation status and VDJ rearrangement structure in mantle cell lymphoma: correlation with genomic aberrations, clinical characteristics, and outcome

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only